866-997-4948(US-Canada Toll Free)

United States Spine Biologics Market Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 106 Pages

In this report, the United States Spine Biologics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Spine Biologics in these regions, from 2012 to 2022 (forecast).

United States Spine Biologics market competition by top manufacturers/players, with Spine Biologics sales volume, price, revenue (Million USD)and market share for each manufacturer/player; the top players including
Medtronic
Depuy Synthes
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
Alphatec Spine
K2M
Exactech
Wright Medical Technology
X-Spine Systems
Nutech
Arthrex

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma
BMAC
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Spine Biologics for each application, including
Anterior Cervical Discectomy and Fusion
Posterior Lumbar Interbody Fusion

Table of Contents

United States Spine Biologics Market Report 2017
1 Spine Biologics Overview
1.1 Product Overview and Scope of Spine Biologics
1.2 Classification of Spine Biologics by Product Category
1.2.1 United States Spine Biologics Market Size (Sales Volume)Comparison by Type (2012-2022)
1.2.2 United States Spine Biologics Market Size (Sales Volume)Market Share by Type (Product Category)in 2016
1.2.3 Bone Graft
1.2.4 Bone Graft Substitute
1.2.5 Platelet Rich Plasma
1.2.6 BMAC
1.3 United States Spine Biologics Market by Application/End Users
1.3.1 United States Spine Biologics Market Size (Consumption)and Market Share Comparison by Application (2012-2022)
1.3.2 Anterior Cervical Discectomy and Fusion
1.3.3 Posterior Lumbar Interbody Fusion
1.4 United States Spine Biologics Market by Region
1.4.1 United States Spine Biologics Market Size (Value)Comparison by Region (2012-2022)
1.4.2 The West Spine Biologics Status and Prospect (2012-2022)
1.4.3 Southwest Spine Biologics Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Spine Biologics Status and Prospect (2012-2022)
1.4.5 New England Spine Biologics Status and Prospect (2012-2022)
1.4.6 The South Spine Biologics Status and Prospect (2012-2022)
1.4.7 The Midwest Spine Biologics Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume)of Spine Biologics (2012-2022)
1.5.1 United States Spine Biologics Sales and Growth Rate (2012-2022)
1.5.2 United States Spine Biologics Revenue and Growth Rate (2012-2022)

2 United States Spine Biologics Market Competition by Players/Suppliers
2.1 United States Spine Biologics Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Spine Biologics Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Spine Biologics Average Price by Players/Suppliers (2012-2017)
2.4 United States Spine Biologics Market Competitive Situation and Trends
2.4.1 United States Spine Biologics Market Concentration Rate
2.4.2 United States Spine Biologics Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Spine Biologics Manufacturing Base Distribution, Sales Area, Product Type

3 United States Spine Biologics Sales (Volume)and Revenue (Value)by Region (2012-2017)
3.1 United States Spine Biologics Sales and Market Share by Region (2012-2017)
3.2 United States Spine Biologics Revenue and Market Share by Region (2012-2017)
3.3 United States Spine Biologics Price by Region (2012-2017)

4 United States Spine Biologics Sales (Volume)and Revenue (Value)by Type (Product Category)(2012-2017)
4.1 United States Spine Biologics Sales and Market Share by Type (Product Category)(2012-2017)
4.2 United States Spine Biologics Revenue and Market Share by Type (2012-2017)
4.3 United States Spine Biologics Price by Type (2012-2017)
4.4 United States Spine Biologics Sales Growth Rate by Type (2012-2017)

5 United States Spine Biologics Sales (Volume)by Application (2012-2017)
5.1 United States Spine Biologics Sales and Market Share by Application (2012-2017)
5.2 United States Spine Biologics Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Spine Biologics Players/Suppliers Profiles and Sales Data
6.1 Medtronic
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Spine Biologics Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Medtronic Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Depuy Synthes
6.2.2 Spine Biologics Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Depuy Synthes Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Stryker Corporation
6.3.2 Spine Biologics Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Stryker Corporation Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Nuvasive
6.4.2 Spine Biologics Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Nuvasive Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Zimmer Biomet
6.5.2 Spine Biologics Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Zimmer Biomet Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Orthofix International
6.6.2 Spine Biologics Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Orthofix International Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Globus Medical
6.7.2 Spine Biologics Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Globus Medical Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Alphatec Spine
6.8.2 Spine Biologics Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Alphatec Spine Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 K2M
6.9.2 Spine Biologics Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 K2M Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Exactech
6.10.2 Spine Biologics Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Exactech Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Wright Medical Technology
6.12 X-Spine Systems
6.13 Nutech
6.14 Arthrex

7 Spine Biologics Manufacturing Cost Analysis
7.1 Spine Biologics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Spine Biologics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Spine Biologics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Spine Biologics Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Spine Biologics Market Size (Value and Volume)Forecast (2017-2022)
11.1 United States Spine Biologics Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Spine Biologics Sales Volume Forecast by Type (2017-2022)
11.3 United States Spine Biologics Sales Volume Forecast by Application (2017-2022)
11.4 United States Spine Biologics Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Spine Biologics
Figure United States Spine Biologics Market Size (K MT)by Type (2012-2022)
Figure United States Spine Biologics Sales Volume Market Share by Type (Product Category)in 2016
Figure Bone Graft Product Picture
Figure Bone Graft Substitute Product Picture
Figure Platelet Rich Plasma Product Picture
Figure BMAC Product Picture
Figure United States Spine Biologics Market Size (K MT)by Application (2012-2022)
Figure United States Sales Market Share of Spine Biologics by Application in 2016
Figure Anterior Cervical Discectomy and Fusion Examples
Figure Posterior Lumbar Interbody Fusion Examples
Figure United States Spine Biologics Market Size (Million USD)by Region (2012-2022)
Figure The West Spine Biologics Revenue (Million USD)and Growth Rate (2012-2022)
Figure Southwest Spine Biologics Revenue (Million USD)and Growth Rate (2012-2022)
Figure The Middle Atlantic Spine Biologics Revenue (Million USD)and Growth Rate (2012-2022)
Figure New England Spine Biologics Revenue (Million USD)and Growth Rate (2012-2022)
Figure The South of US Spine Biologics Revenue (Million USD)and Growth Rate (2012-2022)
Figure The Midwest Spine Biologics Revenue (Million USD)and Growth Rate (2012-2022)
Figure United States Spine Biologics Sales (K MT)and Growth Rate (2012-2022)
Figure United States Spine Biologics Revenue (Million USD)and Growth Rate (2012-2022)
Figure United States Spine Biologics Market Major Players Product Sales Volume (K MT)(2012-2017)
Table United States Spine Biologics Sales (K MT)of Key Players/Suppliers (2012-2017)
Table United States Spine Biologics Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Spine Biologics Sales Share by Players/Suppliers
Figure 2017 United States Spine Biologics Sales Share by Players/Suppliers
Figure United States Spine Biologics Market Major Players Product Revenue (Million USD)(2012-2017)
Table United States Spine Biologics Revenue (Million USD)by Players/Suppliers (2012-2017)
Table United States Spine Biologics Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Spine Biologics Revenue Share by Players/Suppliers
Figure 2017 United States Spine Biologics Revenue Share by Players/Suppliers
Table United States Market Spine Biologics Average Price (USD/MT)of Key Players/Suppliers (2012-2017)
Figure United States Market Spine Biologics Average Price (USD/MT)of Key Players/Suppliers in 2016
Figure United States Spine Biologics Market Share of Top 3 Players/Suppliers
Figure United States Spine Biologics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Spine Biologics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Spine Biologics Product Category
Table United States Spine Biologics Sales (K MT)by Region (2012-2017)
Table United States Spine Biologics Sales Share by Region (2012-2017)
Figure United States Spine Biologics Sales Share by Region (2012-2017)
Figure United States Spine Biologics Sales Market Share by Region in 2016
Table United States Spine Biologics Revenue (Million USD)and Market Share by Region (2012-2017)
Table United States Spine Biologics Revenue Share by Region (2012-2017)
Figure United States Spine Biologics Revenue Market Share by Region (2012-2017)
Figure United States Spine Biologics Revenue Market Share by Region in 2016
Table United States Spine Biologics Price (USD/MT)by Region (2012-2017)
Table United States Spine Biologics Sales (K MT)by Type (2012-2017)
Table United States Spine Biologics Sales Share by Type (2012-2017)
Figure United States Spine Biologics Sales Share by Type (2012-2017)
Figure United States Spine Biologics Sales Market Share by Type in 2016
Table United States Spine Biologics Revenue (Million USD)and Market Share by Type (2012-2017)
Table United States Spine Biologics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Spine Biologics by Type (2012-2017)
Figure Revenue Market Share of Spine Biologics by Type in 2016
Table United States Spine Biologics Price (USD/MT)by Types (2012-2017)
Figure United States Spine Biologics Sales Growth Rate by Type (2012-2017)
Table United States Spine Biologics Sales (K MT)by Application (2012-2017)
Table United States Spine Biologics Sales Market Share by Application (2012-2017)
Figure United States Spine Biologics Sales Market Share by Application (2012-2017)
Figure United States Spine Biologics Sales Market Share by Application in 2016
Table United States Spine Biologics Sales Growth Rate by Application (2012-2017)
Figure United States Spine Biologics Sales Growth Rate by Application (2012-2017)
Table Medtronic Basic Information List
Table Medtronic Spine Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT)and Gross Margin (2012-2017)
Figure Medtronic Spine Biologics Sales Growth Rate (2012-2017)
Figure Medtronic Spine Biologics Sales Market Share in United States (2012-2017)
Figure Medtronic Spine Biologics Revenue Market Share in United States (2012-2017)
Table Depuy Synthes Basic Information List
Table Depuy Synthes Spine Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT)and Gross Margin (2012-2017)
Figure Depuy Synthes Spine Biologics Sales Growth Rate (2012-2017)
Figure Depuy Synthes Spine Biologics Sales Market Share in United States (2012-2017)
Figure Depuy Synthes Spine Biologics Revenue Market Share in United States (2012-2017)
Table Stryker Corporation Basic Information List
Table Stryker Corporation Spine Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT)and Gross Margin (2012-2017)
Figure Stryker Corporation Spine Biologics Sales Growth Rate (2012-2017)
Figure Stryker Corporation Spine Biologics Sales Market Share in United States (2012-2017)
Figure Stryker Corporation Spine Biologics Revenue Market Share in United States (2012-2017)
Table Nuvasive Basic Information List
Table Nuvasive Spine Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT)and Gross Margin (2012-2017)
Figure Nuvasive Spine Biologics Sales Growth Rate (2012-2017)
Figure Nuvasive Spine Biologics Sales Market Share in United States (2012-2017)
Figure Nuvasive Spine Biologics Revenue Market Share in United States (2012-2017)
Table Zimmer Biomet Basic Information List
Table Zimmer Biomet Spine Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT)and Gross Margin (2012-2017)
Figure Zimmer Biomet Spine Biologics Sales Growth Rate (2012-2017)
Figure Zimmer Biomet Spine Biologics Sales Market Share in United States (2012-2017)
Figure Zimmer Biomet Spine Biologics Revenue Market Share in United States (2012-2017)
Table Orthofix International Basic Information List
Table Orthofix International Spine Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT)and Gross Margin (2012-2017)
Figure Orthofix International Spine Biologics Sales Growth Rate (2012-2017)
Figure Orthofix International Spine Biologics Sales Market Share in United States (2012-2017)
Figure Orthofix International Spine Biologics Revenue Market Share in United States (2012-2017)
Table Globus Medical Basic Information List
Table Globus Medical Spine Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT)and Gross Margin (2012-2017)
Figure Globus Medical Spine Biologics Sales Growth Rate (2012-2017)
Figure Globus Medical Spine Biologics Sales Market Share in United States (2012-2017)
Figure Globus Medical Spine Biologics Revenue Market Share in United States (2012-2017)
Table Alphatec Spine Basic Information List
Table Alphatec Spine Spine Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT)and Gross Margin (2012-2017)
Figure Alphatec Spine Spine Biologics Sales Growth Rate (2012-2017)
Figure Alphatec Spine Spine Biologics Sales Market Share in United States (2012-2017)
Figure Alphatec Spine Spine Biologics Revenue Market Share in United States (2012-2017)
Table K2M Basic Information List
Table K2M Spine Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT)and Gross Margin (2012-2017)
Figure K2M Spine Biologics Sales Growth Rate (2012-2017)
Figure K2M Spine Biologics Sales Market Share in United States (2012-2017)
Figure K2M Spine Biologics Revenue Market Share in United States (2012-2017)
Table Exactech Basic Information List
Table Exactech Spine Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT)and Gross Margin (2012-2017)
Figure Exactech Spine Biologics Sales Growth Rate (2012-2017)
Figure Exactech Spine Biologics Sales Market Share in United States (2012-2017)
Figure Exactech Spine Biologics Revenue Market Share in United States (2012-2017)
Table Wright Medical Technology Basic Information List
Table X-Spine Systems Basic Information List
Table Nutech Basic Information List
Table Arthrex Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Spine Biologics
Figure Manufacturing Process Analysis of Spine Biologics
Figure Spine Biologics Industrial Chain Analysis
Table Raw Materials Sources of Spine Biologics Major Players/Suppliers in 2016
Table Major Buyers of Spine Biologics
Table Distributors/Traders List
Figure United States Spine Biologics Sales Volume (K MT)and Growth Rate Forecast (2017-2022)
Figure United States Spine Biologics Revenue (Million USD)and Growth Rate Forecast (2017-2022)
Figure United States Spine Biologics Price (USD/MT)Trend Forecast (2017-2022)
Table United States Spine Biologics Sales Volume (K MT)Forecast by Type (2017-2022)
Figure United States Spine Biologics Sales Volume (K MT)Forecast by Type (2017-2022)
Figure United States Spine Biologics Sales Volume (K MT)Forecast by Type in 2022
Table United States Spine Biologics Sales Volume (K MT)Forecast by Application (2017-2022)
Figure United States Spine Biologics Sales Volume (K MT)Forecast by Application (2017-2022)
Figure United States Spine Biologics Sales Volume (K MT)Forecast by Application in 2022
Table United States Spine Biologics Sales Volume (K MT)Forecast by Region (2017-2022)
Table United States Spine Biologics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Spine Biologics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Spine Biologics Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *